Kaleido Biosciences (KLDO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends KLDO vs. CXAI, ABTS, HKIT, GIGM, GVP, ARBB, IPDN, HRYU, DTSS, and MMVShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include CXApp (CXAI), Abits Group (ABTS), Hitek Global (HKIT), GigaMedia (GIGM), GSE Systems (GVP), ARB IOT Group (ARBB), Professional Diversity Network (IPDN), Hanryu (HRYU), Datasea (DTSS), and MultiMetaVerse (MMV). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. CXApp Abits Group Hitek Global GigaMedia GSE Systems ARB IOT Group Professional Diversity Network Hanryu Datasea MultiMetaVerse Kaleido Biosciences (NASDAQ:KLDO) and CXApp (NASDAQ:CXAI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings. Is KLDO or CXAI more profitable? Kaleido Biosciences has a net margin of 0.00% compared to CXApp's net margin of -751.90%. Kaleido Biosciences' return on equity of 0.00% beat CXApp's return on equity.Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A CXApp -751.90%-281.11%-158.66% Does the media prefer KLDO or CXAI? In the previous week, CXApp had 6 more articles in the media than Kaleido Biosciences. MarketBeat recorded 6 mentions for CXApp and 0 mentions for Kaleido Biosciences. CXApp's average media sentiment score of 0.23 beat Kaleido Biosciences' score of 0.00 indicating that CXApp is being referred to more favorably in the news media. Company Overall Sentiment Kaleido Biosciences Neutral CXApp Neutral Which has more volatility & risk, KLDO or CXAI? Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500. Comparatively, CXApp has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Do insiders and institutionals believe in KLDO or CXAI? 81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 14.4% of CXApp shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 16.2% of CXApp shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer KLDO or CXAI? Kaleido Biosciences received 53 more outperform votes than CXApp when rated by MarketBeat users. However, 100.00% of users gave CXApp an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformKaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% CXAppOutperform Votes1100.00% Underperform VotesNo Votes Which has preferable valuation & earnings, KLDO or CXAI? CXApp has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.00-$95.48M-$2.24N/ACXApp$7.37M2.88-$53.62MN/AN/A SummaryCXApp beats Kaleido Biosciences on 7 of the 12 factors compared between the two stocks. Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.39M$150.91M$5.16B$8.74BDividend YieldN/A3.64%5.18%4.08%P/E Ratio0.00187.6768.5613.82Price / SalesN/A16,673.191,271.8787.50Price / CashN/A12.4639.7135.24Price / BookN/A7.886.485.93Net Income-$95.48M-$20.05M$119.82M$225.73M Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/AN/AN/AN/A$6.39M$1.10M0.0076CXAICXApp0.8739 of 5 stars$1.39-2.8%N/A+2.2%$21.22M$7.37M0.002Earnings ReportShort Interest ↓News CoverageGap UpABTSAbits Group0.0888 of 5 stars$0.59+11.3%N/AN/A$20.95M$1.68M0.0011Short Interest ↑News CoverageGap UpHKITHitek Global1.1968 of 5 stars$1.32-1.5%N/A+17.9%$19M$4.56M0.0075Short Interest ↓Positive NewsGIGMGigaMedia0.3987 of 5 stars$1.50+0.7%N/A+10.3%$16.58M$4.29M-4.1796Short Interest ↑GVPGSE Systems1.9955 of 5 stars$4.59flatN/AN/A$15.93M$45.04M-1.81252Positive NewsARBBARB IOT Group0.6647 of 5 stars$0.48-14.3%N/A-52.0%$12.69M$12.32M0.0053Short Interest ↑News CoverageGap DownIPDNProfessional Diversity Network1.0691 of 5 stars$0.95+5.6%N/A-22.1%$12.54M$7.70M-4.7540Analyst ForecastShort Interest ↓Positive NewsGap DownHigh Trading VolumeHRYUHanryu0.5019 of 5 stars$0.24+4.4%N/A-57.2%$12.43M$790,000.000.0074Short Interest ↑Gap DownDTSSDatasea2.1138 of 5 stars$2.40+0.8%N/A-19.1%$12.37M$23.98M0.00120Short Interest ↓News CoverageGap UpMMVMultiMetaVerseN/A$0.36-2.7%N/A-74.8%$11.90M$9.01M0.0081Short Interest ↓Gap Down Related Companies and Tools Related Companies CXApp Competitors Abits Group Competitors Hitek Global Competitors GigaMedia Competitors GSE Systems Competitors ARB IOT Group Competitors Professional Diversity Network Competitors Hanryu Competitors Datasea Competitors MultiMetaVerse Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KLDO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
